| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| May 17, 2023 | May 18, 2023 | Larimar Therapeutics, Inc. | CEO | Buy | 78.8 | +5,000 | 1.91% | ✗ | $18.5K |
| Sep 16, 2022 | Sep 19, 2022 | Larimar Therapeutics, Inc. | CEO | Buy | 95.0 | +31,746 | 126.56% | ✗ | $100K |